Inhibidores de PCSK-9, efectos sobre el cLDL e implicaciones futuras: lo que se debe saber

The objective of the present article is to review the history of the discovery of PCSK9, its physiology and pathophysiology and subsequent pharmacological development. The objectives and goals reached to date and the pending questions regarding the efficacy and safety of its clinical use are presented.